Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized open-label crossover study of phosphate binders on uremic toxin levels in chronic hemodialysis
MOH_2024-10-09_013688Phase 4Not yet recruiting
- Sponsor
- Edith Wolfson Medical Center
- Start
- Sep 2024
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sevelamer carbonate, lanthanum carbonate and iron sucrose in hyperphosphatemia and end-stage kidney disease (ESKD), sponsored by Edith Wolfson Medical Center. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
sevelamer carbonatelanthanum carbonateiron sucrose
03
Conditions
hyperphosphatemiaend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on MOH_2024-10-09_013688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2024-10-09_013688.